Company / SG&A per Share
AbbVie SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$7.90
FY2025
5-year range
$7.24 / $9.12
FY2021-FY2025
Trend
-4.8%
vs FY2024
Sector context
#21 of 208
Health Care
What the data says
Among 208 Health Care companies, AbbVie is in the bottom 10% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $3.65 in FY2016 to $9.12 in FY2022.
Based on SEC 10-K filings.
7.90 in FY2025 with a 5-year CAGR of +1.6%. Top quartile in the Health Care sector.
Increased from $7.24 to $7.90 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -4.7%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 208This company $7.90 Sector average $29.78
▼
-73.5% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 4.8% year-over-year.
- Ranks #21 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.90 | -4.8% |
| FY2024 | $8.30 | +14.5% |
| FY2023 | $7.24 | -20.6% |
| FY2022 | $9.12 | +9.6% |
| FY2021 | $8.32 | +13.9% |
| FY2020 | $7.31 | +68.8% |
| FY2019 | $4.33 | -4.5% |
| FY2018 | $4.54 | +18.0% |
| FY2017 | $3.85 | +5.3% |
| FY2016 | $3.65 | -8.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026